LEAP-017: Lenvatinib and Pembrolizumab in MSS mCRC

The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.

Related Keywords

Johnl Marshall , ,Genentech ,Lenvatinib ,Pembrolizumab ,Trio Therapy ,Vegf Inhibition ,Refractory Disease ,Physician Choice ,Microsatellite Stable ,